First Time Loading...

Laboratory Corporation of America Holdings
NYSE:LH

Watchlist Manager
Laboratory Corporation of America Holdings Logo
Laboratory Corporation of America Holdings
NYSE:LH
Watchlist
Price: 198.9 USD -0.54%
Updated: Apr 18, 2024

ROE
Return on Equity

4.7%
Current
18%
Average
3%
Industry
Positive for the last year
4.7%
Positive average
18%
Worse than average
Better than industry value

ROE, or Return on Equity, is a key financial ratio that measures a company's profitability. Specifically, it measures how many dollars of profit are generated for each dollar of shareholder's equity. A higher ROE indicates better financial performance and effective use of capital, making it a valuable metric for investors assessing a company's earning potential.

ROE
4.7%
=
Net Income
418m
/
Equity
9.1B

ROE Across Competitors

ROE Comparison
Laboratory Corporation of America Holdings Competitors

Country Company Market Cap ROE
US
Laboratory Corporation of America Holdings
NYSE:LH
16.7B USD
5%
US
Cigna Group
XMUN:CGN
95.5B EUR
11%
US
Cigna Corp
NYSE:CI
103.2B USD
11%
US
CVS Health Corp
NYSE:CVS
89.2B USD
11%
DE
Fresenius Medical Care AG
XMUN:FME
20.5B EUR
4%
DE
Fresenius SE & Co KGaA
XETRA:FRE
15B EUR
-3%
US
Quest Diagnostics Inc
NYSE:DGX
14.1B USD
14%
US
DaVita Inc
NYSE:DVA
11.3B USD
78%
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
10.7B EUR
4%
US
Oak Street Health Inc
NYSE:OSH
9.5B USD
464%
US
Chemed Corp
NYSE:CHE
9.1B USD
29%
Laboratory Corporation of America Holdings
NYSE:LH
Country US
Market Cap 16.7B USD
ROE
5%
C
Cigna Group
XMUN:CGN
Country US
Market Cap 95.5B EUR
ROE
11%
Cigna Corp
NYSE:CI
Country US
Market Cap 103.2B USD
ROE
11%
CVS Health Corp
NYSE:CVS
Country US
Market Cap 89.2B USD
ROE
11%
Fresenius Medical Care AG
XMUN:FME
Country DE
Market Cap 20.5B EUR
ROE
4%
F
Fresenius SE & Co KGaA
XETRA:FRE
Country DE
Market Cap 15B EUR
ROE
-3%
Quest Diagnostics Inc
NYSE:DGX
Country US
Market Cap 14.1B USD
ROE
14%
DaVita Inc
NYSE:DVA
Country US
Market Cap 11.3B USD
ROE
78%
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
Country DE
Market Cap 10.7B EUR
ROE
4%
Oak Street Health Inc
NYSE:OSH
Country US
Market Cap 9.5B USD
ROE
464%
Chemed Corp
NYSE:CHE
Country US
Market Cap 9.1B USD
ROE
29%

Profitability Report

View the profitability report to see the full profitability analysis for Laboratory Corporation of America Holdings.

Full Profitability Report

See Also

Summary
LH intrinsic value, competitors valuation, and company profile.
DCF Valuation
LH stock valuation using Discount Cash Flow valuation method.
Relative Valuation
LH stock valuation using valuation multiples.
Wall Street Estimates
LH price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
LH stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
What is Return on Equity?

ROE, or Return on Equity, is a key financial ratio that measures a company's profitability. Specifically, it measures how many dollars of profit are generated for each dollar of shareholder's equity. A higher ROE indicates better financial performance and effective use of capital, making it a valuable metric for investors assessing a company's earning potential.

ROE
4.7%
=
Net Income
418m
/
Equity
9.1B
What is the ROE of Laboratory Corporation of America Holdings?

Based on Laboratory Corporation of America Holdings's most recent financial statements, the company has ROE of 4.7%.

ALPHA SPREAD
Join more than 128,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.